Skip to content
Home/Companies/Pharma/Laxxon Medical
Laxxon Medical

Laxxon Medical

Pharma·United States·Active·4yr hold
Entry
2022
Hold
4yr
Status
Active

Who owns Laxxon Medical?

Laxxon Medical is an American Pharma company, currently owned by Evonik Venture Capital since 2022.

Hand-verified · updated 2026-08-10

Open JSON · CC-BY
Evonik Venture Capital
Investor
Evonik Venture Capital
Evonik Venture Capital · 2012 · VC

Key facts

HQUnited States
SectorPharma
StatusActive
Websitewww.laxxonmedical.com

More from Evonik Venture Capital

Other portfolio companies in the same fund.

Abolis
Active
BiotechFrance· 2024
JLand Biotech
Active
BiotechChina· 2024
Interface Polymers
Interface Polymers
Active
IndustrialsUK· 2023
SuperC
Active
ClimateTechChina· 2023
Allay Therapeutics
Allay Therapeutics
Active
MedTechUS· 2022
Biograil
Biograil
Active
MedTechDenmark· 2022

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Advantice Health
Advantice Health
Active
TA AssociatesUS
Alcala Farma
Active
Advent InternationalSpain
Alvogen
Alvogen
Active
CVC Capital Partners
Anovo
Anovo
Active
ArdianUS

Questions

Who owns Laxxon Medical?

Laxxon Medical is currently owned by Evonik Venture Capital, through Evonik Venture Capital, since 2022.

When did Evonik Venture Capital acquire Laxxon Medical?

Evonik Venture Capital acquired Laxxon Medical in 2022.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue